Nature’s Sunshine Products, Inc. — 2017 Form 10-K
Business context and reporting period. The company manufactures and direct-sells nutritional and personal-care products through independent distributors and operates four segments: NSP Americas, NSP Russia/Central and Eastern Europe, Synergy WorldWide, and NSP China. This filing covers the fiscal year ended December 31, 2017; quarterly figures below identify the fourth quarter specifically. Dollar amounts are in millions unless noted.
Financial and operating performance
| Metric | 2017 | 2016 |
|---|---|---|
| Net sales | $342.0 | $341.2 |
| Gross profit / gross margin | $251.0 / 73.4% | $250.2 / 73.3% |
| Operating income / margin | $1.4 / 0.4% | $10.0 / 2.9% |
| Income before tax | $3.2 | $9.3 |
| Income tax provision | $17.0 | $8.6 |
| Net income (loss) attributable to common shareholders | $(12.9) | $2.1 |
| Diluted loss / earnings per share | $(0.69) | $0.11 |
| Cash from operating activities | $10.5 | $3.4 |
| Capital expenditures | $5.5 | $11.0 |
- Revenue grew 0.3% as reported, but declined 0.2% excluding foreign-exchange effects. Segment sales were $166.0 million for NSP Americas (down 5.6%), $32.2 million for NSP Russia/Central and Eastern Europe (up 7.3%), $123.8 million for Synergy WorldWide (down 0.8%), and $20.0 million for NSP China (up 91.4%).
- SG&A rose to $129.6 million, or 37.9% of sales, from $120.3 million and 35.3%. Volume incentives were $120.0 million, or 35.1% of sales, broadly unchanged as a percentage.
- At year-end, cash and cash equivalents were $42.9 million, working capital was $48.9 million, and total shareholders’ equity was $119.7 million. Of cash, $32.2 million was held in foreign markets and may be subject to repatriation restrictions or taxes.
- Debt consisted of $13.2 million outstanding under a $25 million revolving facility, with $11.8 million available. The facility matures in July 2020, bears interest at LIBOR plus 1.25%, is secured by company assets, and had compliant covenants at year-end. The company reported no other off-balance-sheet arrangements beyond operating leases.
- For the fourth quarter, sales were $88.3 million versus $84.0 million a year earlier; operating loss was $2.8 million versus $1.4 million. Net loss attributable to common shareholders was $17.4 million, or $0.92 per share, compared with a $6.7 million loss, or $0.35 per share.
Material changes and management commentary
- The Oracle ERP system began implementation in NSP Americas and corporate operations in April 2017. Ordering and call-center disruption contributed to lower sales, increased customer attrition, and weaker profitability; management said the issues had been addressed but that the Americas business baseline was lower. Active distributors and customers worldwide fell to 230,900 from 241,500; active Managers were approximately 13,000, versus 12,900.
- SG&A increases included China service fees and infrastructure investment, and Oracle-related depreciation and other costs. Management reported approximately $48 million invested in information systems by year-end.
- The company received a China direct-selling license in May 2017, supporting expansion there. China revenue nearly doubled, while South Korea sales fell amid reduced distributor engagement, geopolitical tension, and economic conditions; Japan grew strongly.
- A fourth-quarter restructuring eliminated 60 positions, ended operations in Costa Rica and Nicaragua, and closed the Los Angeles office. Related 2017 expense was approximately $1.5 million.
- The board suspended quarterly dividends after the $0.10-per-share payment made in April 2017. No further 2017 dividends were declared.
- The 2017 tax provision reflected the Tax Cuts and Jobs Act, valuation allowances, and remeasurement of deferred taxes. The company reported a 528.8% effective tax rate and a $12.9 million net loss attributable to common shareholders despite positive pretax income. Certain tax accounting estimates remained provisional.
- Management stated that operating cash, available cash, and credit availability should fund normal operating needs and capital expenditures, but provided no quantified revenue or earnings guidance.
Risks, contingencies, and unusual items
- Key risks include direct-selling and product regulation, distributor retention and productivity, product claims and liability, China licensing and regulatory discretion, the China joint venture, foreign-exchange exposure, and dependence on suppliers, manufacturing, information systems, and third-party distributors.
- Management disclosed various legal proceedings and tax matters whose outcomes are uncertain. The company accrued $1.5 million for other litigation and reported possible future payments of up to approximately $1.9 million for certain other matters; non-income tax contingency payments were estimated at $0 to $4.0 million, with $0.4 million accrued for the specified non-income tax matters.
- Foreign-exchange sensitivity analysis indicated that a hypothetical 10% strengthening of the U.S. dollar against fluctuating currencies would reduce reported operating income by an estimated $0.3 million, based on 2017 operations.
- The independent auditor issued unqualified opinions on the financial statements and internal control over financial reporting; management also concluded disclosure controls and internal control were effective at year-end.
Important facts for investors to verify
- Whether post-ERP service improvements stabilize NSP Americas revenue, distributor counts, and customer retention.
- Whether China’s license translates into sustainable sales and contribution after service fees, infrastructure spending, and regulatory constraints.
- Whether margins recover as SG&A and Oracle-related costs evolve, and how the 2017 tax effects compare with recurring tax expense.
- Cash accessibility outside the United States, revolving-credit covenants and collateral, and the company’s capacity to meet operating and lease commitments.
- Developments in disclosed litigation, non-income tax matters, product-liability exposure, and distributor or product-claim compliance.